Immuneering Corp (IMRX) support and resistance · $124.2M cap
Immuneering Corp (IMRX) is a biotechnology company listed on US.
This page maps Immuneering Corp (IMRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
IMRX currently screens at market cap $124.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMRX quote page for the session range and the stock page for the full model.
Not investment advice.